Articles and Blogs

As the NCAA March Madness tournaments heat up, lawmakers and the Trump administration are making their own plays on key federal telehealth policy issues. On March 15, the President signed the Full-Year Continuing Appropriations and Extensions Act, 2025 (“Continuing Resolution”) to fund the federal government through September 30. The Continuing Resolution extends several key... READ MORE

On Friday, February 24, 2023, the Drug Enforcement Administration (“DEA”) proposed new regulations that would permanently allow for telemedicine-controlled substance prescriptions, including induction of medication assisted therapy (“MAT”) using buprenorphine. These long-awaited rules will be subject to an accelerated, 30-day notice and comment period that ends March 31, 2023 to allow for implementation prior... READ MORE